Stem Cells Spin S.A.

Equities

SCS

PLSTCLS00013

Biotechnology & Medical Research

End-of-day quote Warsaw S.E. Other stock markets 18:00:00 2024-05-09 EDT			5-day change	1st Jan Change
0.52 ^PLN	0.00%		0.00%	+52.94%

02-14	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
02-14	Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Astoria Capital Spólka Akcyjna sold 9.28% stake in Stem Cells Spin Spólka Akcyjna.

January 22, 2015 at 11:00 pm

Astoria Capital Spólka Akcyjna (WSE:ACL) sold 9.28% stake in Stem Cells Spin Spólka Akcyjna (WSE:SCS) on January 23, 2015. Astoria Capital Spólka Akcyjna sold 1.2 million shares in Stem Cells Spin Spólka Akcyjna.

Astoria Capital Spólka Akcyjna (WSE:ACL) completed the sale of 9.28% stake in Stem Cells Spin Spólka Akcyjna (WSE:SCS) on January 23, 2015.

Latest news about Stem Cells Spin S.A.

Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	02-14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI
Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-15	CI
Astoria Capital Spólka Akcyjna sold 9.28% stake in Stem Cells Spin Spólka Akcyjna.	15-01-22	CI

Chart Stem Cells Spin S.A.

Duration

Period

More charts

Company Profile

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
STEM CELLS SPIN S.A.	+52.94%	5.38M
MODERNA, INC.	+17.96%	44.96B
IQVIA HOLDINGS INC.	+1.17%	42.65B
LONZA GROUP AG	+48.77%	41.85B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+11.42%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.39%	19.03B
BIO-TECHNE CORPORATION	+4.86%	12.75B
MEDPACE HOLDINGS, INC.	+27.29%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.50%	11.75B

Other Biotechnology & Medical Research